We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.29B
AUM Growth
+$73M
Cap. Flow
+$288M
Cap. Flow %
8.77%
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$42.5M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.3M
3
SEER icon
Seer Inc
SEER
+$20.8M
4
GKOS icon
Glaukos
GKOS
+$17.9M
5
COO icon
Cooper Companies
COO
+$17.1M

Top Sells

Rank Stock Value
1
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$60.7M
2
NTLA icon
Intellia Therapeutics
NTLA
+$26.2M
3
ORGO icon
Organogenesis Holdings
ORGO
+$19.9M
4
LLY icon
Eli Lilly
LLY
+$15.1M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Consumer Staples 0.8%
3 Technology 0.71%
4 Industrials 0.71%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALT icon
251
PUT
Altimmune
ALT
$570M
$441K 0.01%
+39,000
New +$474K
TCDA
252
DELISTED
Tricida, Inc. Common Stock
TCDA
$441K 0.01%
95,022
+39,402
+71% +$163K
ABUS icon
253
Arbutus Biopharma
ABUS
$907M
$429K 0.01%
+100,000
New +$333K
EDIT icon
254
Editas Medicine
EDIT
$436M
$411K 0.01%
+10,000
New +$548K
KALV
255
DELISTED
KalVista Pharmaceuticals
KALV
$383K 0.01%
21,948
+1,992
+10% +$40.4K
KYNB
256
Kyntra Bio
KYNB
$28.7M
$356K 0.01%
+1,395
New +$494K
BCLI
257
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$353K 0.01%
+7,122
New +$375K
IONS icon
258
PUT
Ionis Pharmaceuticals
IONS
$9.39B
$352K 0.01%
+10,500
New +$396K
TALKW
259
DELISTED
Talkspace Inc Warrant
TALKW
$339K 0.01%
440,455
-7,101
-2% -$7.46K
ISEE
260
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$328K 0.01%
+20,200
New +$220K
BCLI
261
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$321K 0.01%
+6,493
New +$342K
BYSI icon
262
BeyondSpring
BYSI
$30.5M
$317K 0.01%
+20,100
New +$361K
MAACW
263
DELISTED
Montes Archimedes Acquisition Corp. Warrant
MAACW
$306K 0.01%
+205,400
New +$277K
BYSI icon
264
PUT
BeyondSpring
BYSI
$30.5M
$266K 0.01%
+16,900
New +$304K
FTH
265
Faeth Therapeutics
FTH
$757M
$238K 0.01%
1,130
– –
ACIU icon
266
AC Immune
ACIU
$267M
$235K 0.01%
+35,000
New +$251K
MAPSW
267
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$216K 0.01%
50,000
– –
TCACU
268
DELISTED
Tuatara Capital Acquisition Corporation Unit
TCACU
$200K 0.01%
20,000
– –
SVRA icon
269
Savara
SVRA
$1.17B
$134K ﹤0.01%
97,461
-1,987
-2% -$2.68K
CYPH
270
Cypherpunk Technologies Inc
CYPH
$70M
$100K ﹤0.01%
+2,500
New +$47K
PHAS
271
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$87K ﹤0.01%
+27,944
New +$93.2K
RCOR.WS
272
DELISTED
Renovacor, Inc. Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11. 50 per whole share
RCOR.WS
$85K ﹤0.01%
+150,632
New +$118K
ABBV icon
273
CALL
AbbVie
ABBV
$440B
– –
-65,800
Closed -$7.41M
ABM icon
274
PUT
ABM Industries
ABM
$2.84B
– –
-150,000
Closed -$6.65M
ABT icon
275
CALL
Abbott
ABT
$192B
– –
-200,000
Closed -$23.2M
9 10
11
12 13

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.

  • Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
  • Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
  • Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
  • Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
  • Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
  • Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
  • Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.